Catalyst Pharmaceuticals
Trade Catalyst Pharmaceuticals 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About CPRX
Catalyst Pharmaceuticals, Inc. is a commercial-stage, patient-centric biopharmaceutical company, which focuses on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult to treat diseases. The company was founded by Hubert E.
CPRX Key Statistics
Stock Snapshot
With a market cap of 3.04B, Catalyst Pharmaceuticals(CPRX) trades at $24.17. The stock has a price-to-earnings ratio of 14.19.
On 2025-12-23, Catalyst Pharmaceuticals(CPRX) stock moved within a range of $24.06 to $24.59. With shares now at $24.17, the stock is trading +0.5% above its intraday low and -1.7% below the session's peak.
Trading volume for Catalyst Pharmaceuticals(CPRX) stock has reached 284.06K, versus its average volume of 1.66M.
The stock's 52-week range extends from a low of $19.05 to a high of $26.58.
The stock's 52-week range extends from a low of $19.05 to a high of $26.58.
CPRX News
Investors in Catalyst Pharmaceuticals Inc (Symbol: CPRX) saw new options begin trading this week, for the February 2026 expiration. At Stock Options Channel , o...
